Health Report
Antibiotics that have saved millions of lives over the decades can no longer always do the job they once did. In a development that has alarmed global health institutions, bacteria are increasingly able to resist the drugs used to kill them, including some powerful antibiotics usually reserved for the most serious cases.
In new warnings issued in recent days, the World Health Organization and the European Centre for Disease Prevention and Control reported that bacterial resistance to antibiotics is worsening, with high levels of resistance in bacteria responsible for serious infections in hospitals.
WHO data indicate that about one in six laboratory-confirmed bacterial infections worldwide was resistant to antibiotics in 2023.
The danger is not that a new disease will emerge, but that familiar, treatable illnesses may become harder to treat, and that surgery, cancer treatment and childbirth may lose some of the protection that effective antibiotics provide.
1. What did the latest WHO data reveal?
On November 18, 2026, the World Health Organization and the European Centre for Disease Prevention and Control published a joint analysis of antibiotic resistance data collected in 2025.
The findings showed that in about half of the countries that reported data, at least half of the samples of two types of bacteria linked to serious hospital infections were resistant to key antibiotics.
Key findings included:
Klebsiella pneumoniae:
In 21 of the 43 countries that reported data, at least half of the samples were resistant to third-generation cephalosporins, a class of antibiotics used to treat serious bacterial infections.
In 10 of the 43 countries, resistance to carbapenems in these bacteria reached 50% or higher.
Acinetobacter:
In 21 of the 38 countries that reported data, at least half of the samples were resistant to carbapenems, broad-spectrum drugs typically used when infections do not respond to other treatments.
These figures are particularly significant because both types of bacteria are linked to hospital infections, including bloodstream infections and conditions that can progress rapidly in patients with weakened immune systems.
The WHO emphasizes that the figures reflect laboratory test results for the samples reported and do not mean that half of all patients in those countries will fail to respond to treatment.
2. How do bacteria become resistant to antibiotics?
Antibiotic resistance does not mean the human body becomes resistant to a drug. It means that bacteria themselves develop mechanisms that allow them to survive and multiply in the presence of an antibiotic.
This process occurs naturally through evolution and genetic changes, but it accelerates when antibiotics are overused or used inappropriately.
Some of the main mechanisms bacteria use include:
-
Producing enzymes that can inactivate some antibiotics.
-
Altering the sites that the drug targets within the bacterial cell.
-
Making the cell wall less permeable to the antibiotic.
-
Using pumps that expel the drug from the cell.
-
Acquiring resistance genes from other bacteria.
As these traits spread, some drugs become less effective, and medical teams may have to use stronger, more expensive antibiotics while closely monitoring the response.
More worrying still, some bacteria can become resistant to more than one class of drugs, narrowing the available treatment options.
3. Hospitals at the heart of the crisis
Hospitals are among the settings most vulnerable to the spread of resistant bacteria because they care for patients with weakened immune systems, use catheters and other medical devices, perform surgery and see repeated exposure to antibiotics.
Healthcare-associated infections include infections of the bloodstream, respiratory tract, urinary tract and surgical wounds.
When bacteria are resistant to standard treatments, doctors may need to run additional tests to determine which antibiotics still work against them.
A delayed diagnosis can also delay effective treatment, prolong hospital stays and raise healthcare costs.
The WHO warns that patients who do not respond to the first antibiotic used to treat a serious infection are more likely to die in hospital.
4. Europe is losing ground on its 2030 targets
The warnings went beyond rising resistance levels. European data also showed that some of the health targets set for 2030 are now further out of reach.
The European Union set targets for reducing bloodstream infections caused by antibiotic-resistant bacteria compared with 2019 levels.
But the figures recorded between 2019 and 2025 showed:
-
Infections with carbapenem-resistant Klebsiella pneumoniae rose by about 72%, rather than falling by the target of 5%.
-
Infections with Escherichia coli resistant to third-generation cephalosporins rose by about 16.4%, rather than falling by the target of 10%.
-
Infections with methicillin-resistant Staphylococcus aureus (MRSA) fell by about 19%, exceeding the reduction target of 15%.
These figures s how that tackling resistance is not an impossible task. Progress has already been made with some types of infection, but it requires funding, surveillance and sustained implementation of health policies.
5. The world has plans but is falling short on implementation
In a separate global report released on November 16, the WHO revealed a wide gap between government plans and countries’ ability to put them into practice.
Of the 183 countries assessed:
-
173 reported having a national plan to tackle antimicrobial resistance.
-
Only 42 reported that their plans were funded and being implemented.
-
Only 36% reported having a national reference laboratory capable of carrying out the necessary tests for resistance in bacteria and fungi.
-
63% had guidelines on the appropriate use of antimicrobials.
These indicators suggest that the problem is not just a lack of medical knowledge, but also a shortage of funding, laboratories, and diagnostic and surveillance capacity.
The WHO also warned that the development of new antibiotics is not keeping pace with the spread of resistance, making it a global health priority to preserve the effectiveness of existing drugs.
6. Could we face a world in which antibiotics no longer work?
Experts warn that if current trends continue, medicine could return to an era in which some bacterial infections are far more dangerous than they have been in recent decades.
Antibiotics do more than treat minor infections. They are a cornerstone of modern medicine.
Without effective antibiotics, the following would become more complicated and risky:
-
Heart surgery and organ transplants.
-
Cancer treatment with chemotherapy.
-
Cesarean sections and, in some cases, childbirth.
-
Treatment of severe injuries and burns.
-
Intensive care and treatment of bloodstream infections.
That is because bacterial infections that can usually be brought under control may become difficult to treat.
According to WHO estimates reported by Reuters, drug-resistant infections could contribute to more than 39 million deaths worldwide over the next 25 years if current trends continue.
This does not mean those deaths are inevitable. It is an estimate of the risk if effective action is not taken.
7. What is happening in Lebanon and the Arab region?
The issue is especially important for health systems in the Middle East, where tackling antibiotic resistance requires oversight of prescribing and dispensing, stronger laboratory capacity and tighter infection control in hospitals.
For Lebanon, three areas warrant particular attention:
Unregulated antibiotic use: Curbing the use of antibiotics without a prescription or for illnesses that do not respond to them, such as viral infections.
Laboratory surveillance: Strengthening laboratories’ capacity to perform bacterial cultures and antibiotic susceptibility testing so that treatment does not rely on guesswork alone.
Hospital infection control: Applying sterilization and hygiene protocols and monitoring the spread of bacteria between patients, especially in intensive care units.
The published global data cited here do not provide enough recent figures to determine bacterial resistance rates in Lebanon accurately, so the European figures should not be applied directly to Lebanese hospitals.
The challenge, however, calls for stronger national surveillance and regular publication of data on bacterial species and their levels of drug resistance.
8. How can you protect yourself and your family?
Health institutions emphasize that tackling antibiotic resistance is not just the job of doctors and hospitals. It also starts with the choices individuals make.
Key steps include:
-
Do not take antibiotics without a prescription.
-
Do not use antibiotics left over from a previous course of treatment.
-
Do not share medicines with family members.
-
Do not use antibiotics to treat colds or flu, as both are caused by viruses.
-
Follow your doctor’s instructions on the dose and length of treatment, and do not change or stop treatment on your own.
-
Wash your hands, practice good food hygiene and take steps to prevent infections.
-
Keep up with recommended vaccinations to prevent illnesses that may require antibiotic treatment.
-
Do not insist on an antibiotic prescription if your doctor says it is unnecessary.
Responsible antibiotic use in animal husbandry and agriculture is also an important part of the response, because resistance can spread among people, animals, food and the environment.
Conclusion: Protecting antibiotics is a responsibility that goes beyond hospitals
The WHO’s latest warnings are not just an alert about one type of bacteria or one class of drugs. They draw attention to a problem that threatens one of modern medicine’s most important achievements.
The antibiotics that made bacterial infections treatable and saved millions of lives could gradually lose their effectiveness if overuse, inadequate diagnosis and the spread of infections in healthcare facilities continue.
There is still time to contain the crisis through early diagnosis, responsible drug use, stronger laboratories, investment in research on new antibiotics and measures to prevent infections.
Medicine’s next battle will be not only to discover new drugs, but also to keep existing ones working so they can continue to save lives.
If antibiotics lose their effectiveness, the risk will extend beyond the treatment of infections to the future of surgery, organ transplantation, cancer treatment and modern medicine as a whole.
Sources and references:
-
World Health Organization – Report on antibiotic resistance in the European Region, November 18, 2026.
-
World Health Organization – Global report on plans to tackle antimicrobial resistance, November 16, 2026.
-
European Centre for Disease Prevention and Control (ECDC) – Antibiotic resistance data for 2025.
-
Reuters – Report on global progress in tackling antibiotic resistance, November 16, 2026.
-
World Health Organization – World Antimicrobial Resistance Awareness Campaign, November 18–24, 2026.


